FRIDAY, April 12, 2024 (HealthDay News) — Probiotics and vitamin D supplementation may have beneficial effects on cognitive function in patients with schizophrenia, a study shows Published online. Neuropsychopharmacology report.
Aida Mohammadi of the Iranian University of Social Welfare and Rehabilitation Sciences and colleagues investigated the effects of probiotics/vitamin D (400 IU) supplementation on cognitive function and disease severity in 69 patients (18-65 years old) with schizophrenia. evaluated.
Researchers found that Montreal Cognitive Assessment (MoCA) scores increased by 1.96 units in the probiotic-containing supplement group and the group taking a placebo. Furthermore, the proportion of people with a MoCA score of 26 or higher increased significantly in the intervention group. Significant reductions in total cholesterol, fasting blood glucose, and C-reactive protein were seen in the supplement and placebo groups. Taking probiotic supplements tended to reduce positive and negative syndrome scale scores, but the difference between study groups was not statistically significant.
“Targeting the microbiota-gut-brain axis through co-administration of probiotics and vitamin D may provide a new approach to promoting mental health,” the authors wrote. ing.
Summary/Full text
